Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

Innate Immunity in Allergic Asthma

University of Central Florida · NCT06068335

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18+ · All sexes
Healthy volunteers
Accepted
Study type
Observational
Target enrollment
100
US sites recruiting
1
Study start
October 18, 2021
Record last updated
December 6, 2024

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

The purpose of this study is to determine whether a potential type 2 signature, obtained through stimulation of cell lines with various allergens in vitro, correlates with an allergic or asthmatic disease state ex vivo. This type 2 signature will be multi-hierarchical in nature and will be comprised cell surface receptor expression, pathway activation, and gene upregulation.

Conditions: Asthma

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Participants must be at least 18 years of age
  • no history of allergic disease (healthy controls), have clinically diagnosed allergies, or have clinically diagnosed asthma.

Exclusion Criteria

  • Pregnant women and prisoners will be excluded from the study.
  • Individuals currently suffering from any acute infections and those known to suffer from light-headedness will be excluded.

Recruiting US locations

Study contacts (from the official record)

  • Amoy Fraser, PhD, CCRP, PMP · 4072668742 · amoy.fraser@ucf.edu
  • Erica Martin, B.S. · 4072668742 · erica.martin@ucf.edu
Innate Immunity in Allergic Asthma (NCT06068335) | Bored Studies